-

Image
jim fruchterman

Human rights groups have only two assets: people and information.  Learn about Benetech's decade of putting information technology tools into the hands of human rights activists, with the goal of making these two assets more effective in advancing the global cause of human rights.  


Bio


Jim Fruchterman is the founder and CEO of Benetech, a Silicon Valley nonprofit technology company that develops software applications to address unmet needs of users in the social sector. He is the recipient of numerous awards recognizing his work as a pioneering social entrepreneur, including the MacArthur Fellowship, Caltech's Distinguished Alumni Award, the Skoll Award for Social Entrepreneurship, and the Migel Medal - the highest honor in the blindness field - from the American Foundation for the Blind. Since its founding in 1989, Benetech has touched the lives of hundreds of thousands of people. Its tools and services have transformed the ways in which people with disabilities access printed information, at-risk human rights defenders safely document abuse, and environmental practitioners succeed in their efforts to protect species and ecosystems. Through his work with Benetech and as a trailblazer in the field of social entrepreneurship, Jim continues to advance his vision of a world in which the benefits of technology reach all of humanity, not just the wealthiest and most able five percent.
 

Wallenberg Theatre

450 Serra Mall #124

(The room is located in the main quad, across the road from Stanford Oval.)
 

Seminars
-

"Studying Systemic Lupus in Sweden: Pros and Cons of Register-based Data in the Setting of a Chronic Disease"

 

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

 

Abstract

National registers such as the Scandinavian Health Registers are often viewed as a holy grail. These types of data have been used for decades, predating the big data buzz. While the population-based nature of these data overcome many methodologic challenges regarding appropriate control selection, representativeness, generalizability, and statistical power, their limitations should be equally acknowledged. Using a current national register linkage across nearly one dozen Swedish registers, this talk will highlight obstacles and benefits in the setting of reproductive and perinatal outcomes in systemic lupus erythematosus (SLE), a chronic inflammatory disease.

Julia Simard Health Research and Policy
Seminars
-

"Trade-offs of simplifying complex choices: early evidence from the ACA Exchages"

 

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

 

Using new data from the early years of the federally-facilitated Health Insurance Marketplaces (or ACA Exchanges), we explore which factors affect the health insurance choices of the non-elderly population targeted by the ACA. A growing literature has documented potential behavioral biases and high cost of decision-making in various insurance settings that rely on consumer choice - from retirement savings to prescription drug plans. A natural conclusion from this literature is that it may be optimal for policy-makers to introduce behavioral nudges (e.g. optimal defaults, framing) that could reduce the behavioral biases or decision-making costs. For example, ACA Exchanges use "metal level" classification of plans as a framing that reduces the complexity of comparisons across dozens of plans on the Exchanges. So far, we have little evidence on how such nudges work in practice, and whether they are strictly welfare-improving or may lead to unintended consequences. In this project we attempt to start closing this gap by exploring whether the metal tier framing affects choices in the federally facilitated Health Insurance Marketplaces.

Maria Polyakova Health Research and Policy
Seminars
-

"Plastic Surgery or Primary Care? Altruistic Preferences and Expected Specialty Choice of U.S. Medical Students"

 

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

 

Understanding physicians' decisions when faced with conflicts between their own financial self-interest and patients? economic or health interests is of key importance in health economics and policy. This issue is especially salient in certain medical specialties where less altruistic behavior of physicians can yield significant financial gains. This study adopts an experimental approach to examine altruistic preferences of medical students from schools around the U.S. and whether these preferences predict those students? expected medical specialty choice. The experimental design consists of a set of computer-based revealed preference decision problems which ask the experimental subjects to allocate real money between themselves and an anonymous person. These data are used to derive an innovative measure of altruism for each participant which we are the first to apply in health economics. We then examine the association between altruism and expected specialty choice, after controlling for an extensive set of covariates collected from a survey questionnaire which we fielded. We find substantial heterogeneity in altruistic preferences among experimental subjects. Medical students with a lower degree of altruism are significantly more likely to choose high-income specialties. This altruism measure is more predictive of specialty than a wide range of other characteristics including parental income, student loan amount and Medical College Admission Test (MCAT) score.

Jing Li PhD Candidate UC Berkeley
Seminars
-

"Measuring the Impact of Nurse Staffing on Patient Outcomes: The Effect of Data Aggregation and Estimation Methods"

 

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

 

Research Objectives: A growing body of evidence shows that nurse staffing levels and composition affect patient outcomes.  This evidence has come from difference data sources, with different levels of data aggregation, and used different estimation methods.  The problem of unobserved heterogeneity (unobserved characteristics that affect outcomes) is large for this area of research and estimates that don’t address this are almost certainly biased.  We used a large, longitudinal, patient-level dataset with monthly, unit-level nurse staffing data to examine how different levels of data aggregation and different statistical methods affected the estimates of the effect of nurse staffing on patient outcomes.

Study Design:  Monthly staffing for each unit, for each type of nurse (registered nurse, Licensed Practical Nurses, nursing aides, contract nurses), were obtained from VA accounting data.  Payroll data provided education levels and how ng each nurse had worked on the unit (unit tenure).  Patient characteristics and length of stay (LOS) were obtained from VA hospital discharge records.  Log(LOS) was used as the dependent variable as it captures the effect of many nursing-sensitive patient outcomes.  The model controlled for patient age, expected LOS, and patient co-morbidities; the variables of interest were nurse staffing, nurse skill-mix, and unit tenure.  The models were estimated using both ordinary least squares (OLS) and fixed-effects (FE) regressions; the latter was used to address unobserved heterogeneity.  All regressions were patient-level, with different levels of aggregation for the nurse staffing variables (unit-month, unit-year, hospital-month, and hospital-year) and the unit level models were estimated for all units together, and separately for acute care units and intensive care units. 

Population Studied:  All VA acute medical care units (including ICUs) for 2003-2006.  1,923,048 patients from 427 units across 138 VA Medical Centers.

Principal Findings:  The results were quite sensitive to both estimation method and unit of aggregation.  The change in the point estimates of the effects of nurse staffing on LOS of switching from monthly to annual staffing data ranged from 14-1177% for the FE models and 13-276% (plus two reversals, -0.20 to 0.27 and -0.09 to 0.40) for the OLS models.  These ranges were even larger across all levels of aggregation.  For the same level of aggregation, the difference between the OLS and FE estimates ranged from 0-304% and there were two cases of sign reversal (-0.21 to 0.27 and -0.19 to 0.30).

Conclusions:  The magnitude and even the direction of the effects of different elements of nurse staffing on patient outcomes are quite sensitive to the level of aggregation and estimation method. 

Implications for Policy or Practice:  Interpretation of the results of studies of nurse staffing on patient outcomes needs to account for the level of data aggregation and the statistical methods used.  Higher levels of aggregation, both across time and across units, probably masks effects.  Thus, studies that measure nurse staffing at the unit-level data with shorter time intervals yield more reliable estimates.  Studies that fail to account for unobserved heterogeneity are probably biased.  But, FE models also have limits, as they only estimate marginal effects and can’t directly compare the effects of high vs. low staffing levels.

Ciaran S. Phibbs
Seminars
-

"Equalizing child sex ratios in India: Understanding the trends, distribution, composition, potential drivers, and impact on fertility"

 

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

 

Abstract

I will present on the findings of my research on the changing patterns of child sex ratios in India, this includes an exploration of whether child sex ratios are improving in districts with the most uneven child sex ratios in recent years, and what factors are associated with this improvement. I also decompose the improvements in child sex ratios into improvements due to less sex selective abortion vs improved girl child mortality compared to boy child mortality. I then discuss initial findings on potential drivers of the improvement, with the hope to spark a discussion on other ways to think about these findings, specifically related to measuring the impact of policies. Finally, I will present some very preliminary findings from a work in progress on how sex preferences are impacting overall fertility in India.

Nadia Diamond-Smith Postdoctoral Fellow UCSF
Seminars
-

"Re-tooling cost-effectiveness analysis for global health relevance"

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

To identify priorities for action in global health, decision makers need information on the potential impact, costs and cost effectiveness of different possible choices regarding health technologies and interventions. A large volume of cost-effectiveness analysis has been produced to try to meet this need, but its impact on policies and programs in low- and middle-income countries has evidently been limited. In this seminar we will explore some possible reasons for the relatively modest policy impact of cost-effectiveness analysis in global health and propose directions for re-thinking the approaches and methods that are commonly used in the field. Drawing examples from our recent and ongoing research in areas such as HIV/AIDS, tuberculosis and maternal and child health, we will describe an agenda to pivot the practice of decision science in global health toward a more systematic approach to comparative strategy evaluation.

 

Joshua Salomon Professor of Global Health Harvard School of Public Health
Seminars
-

"Wisdom of the Crowd or Tyranny of the Mob? OrderRex: Data-Mining Electronic Health Records for Clinical Decision Support"

 

Please note: All research in progress seminars are off-the-record. Any information about methodology and/or results is embargoed until publication.

 

Background

Uncertainty and undesirable variability is pervasive in medical decision making.  Clinical decision support like order sets help distribute expertise, but are constrained by resource intensive manual development. 

Objective

To overcome scalability limitations by automatically generating decision support content from existing practice patterns, analogous to Amazon.com’s product recommender.  To perform the first structured validation of such a system against external standards-of-care and outcome predictions.

Methods

We extracted deidentified electronic health record data from all hospitalizations at Stanford Hospital in 2011 (>5.4M structured data items from >19K patients) to build a system with association statistics for 811 clinical orders (e.g., labs, imaging, medications) and clinical outcomes.  We manually reviewed the National Guideline Clearinghouse for diagnoses of chest pain, gastrointestinal hemorrhage, and pneumonia.  We compared system generated clinical orders against guideline referenced orders by receiver operating characteristic (ROC) analysis.  Human authored order sets provided real-world benchmarks.  We compared predicted vs. actual outcomes by ROC analysis for separate validation patients.

Results

System generated orders were overall consistent with guidelines (ROC AUC c-statistics 0.89, 0.95, 0.83) and improve upon statistical prevalence (0.76, 0.74, 0.73) and pre-existing order sets (0.81, 0.77, 0.73) (P<10-30 in all cases).  Clinical outcome prediction ROC AUC c-statistics were 0.84 for 30 day mortality , 0.84 for 1 week ICU life support, 0.80 for 1 week discharge / length of stay, and 0.68 for 30 day readmission.

Conclusions

Automatically generated order suggestions can reproduce and even optimize manual constructs like order sets while remaining largely concordant with guidelines and avoiding inappropriate recommendations.  This has even more important implications for prevalent cases where well-defined guidelines and order sets do not exist.  The same methodology is predictive of clinical outcomes comparable to state-of-the-art prognosis models (e.g., APACHE II), pointing to opportunities to link suggestions against favorable outcomes.

Jonathan Chen
Seminars
-

Abstract: A number of senior Intelligence Community (IC) officials describe compliance as one of the IC’s biggest problems, perhaps the biggest. The underlying legal and informational issues are bound to become more acute and complex.  How can AI help? The IC protects our nation by analyzing the relationships between people, places, and things - essentially "connecting the dots.”  Doing so while remaining compliant with policies such as Executive Order 12333[1] and Presidential Policy Directive 28[2] is a balancing act. The interpretation, implementation, and enforcement of policy vary across organizations and administrations.  This frequently leaves analysts struggling to determine what data they can and cannot look at. The Internet, mobile, and “Big Data” generally further complicate the problem. The sheer volume, velocity, and variety of data that is constantly being generated necessitate automation, and even AI, to manage.  However, the benefits of analytic automation over the data deluge will remain limited, until the IC finds a way to scale the processing of legal judgments at a comparable rate.

Before we consider the potential benefits to AI-based methodologies we need to understand two things: Data Rights and Application Uncertainty. Data rights are data attributes derived from laws and dependent institutional policies.  Data rights include but are not limited to classifications, access policies, source limitations, “privacy” constraints, etc. While such data rights are entailed in the data itself, the interpretation and application of these rights are contextual and will vary.  More specifically, application of laws on a data set may be indeterminate: they may vary by time, user, and/or geography; the Second Circuit may issue an unexpected, divergent opinion; access may occur before or after a seminal FISA decision; the Office of Legal Counsel may change its mind; the legal state of a data set at the time of collection may be indeterminate; etc. 
 
About the Speakers: As Executive Vice President at In-Q-Tel, Bob Gleichauf supports technology advancement programs. He is also Director of IQT’s Lab41 initiative, a unique Silicon Valley-based challenge lab that provides “innovation through collaboration” in the area of Big Data analytics. Gleichauf joined IQT from Cisco Systems, where he spent a decade working on the development of secure network infrastructures across a variety of the company’s products. Gleichauf, who has more than a dozen patents in network security, served as CTO for the Wireless and Security Technology Group at Cisco, and is respected globally for his work in information security. He previously served as head of product engineering for the WheelGroup prior to its acquisition by Cisco. Earlier, he was with IQ Software, a leader in the development of database report writing tools. Before making the leap into technology, Gleichauf pursued a Ph.D. in Early Human Prehistory at the University of Michigan, where he earned a fellowship and had the privilege of working in East Africa with the celebrated Leakey family.
 
Joshua H. Walker is an Intellectual Property (IP) partner at Greenberg Traurig, LLP, handling all aspects of IP strategy and transactions, and a legal informatics entrepreneur. Josh has built his career at the nexus of law and computer science. Historically, as an analyst, his work has included helping prosecutors convict orchestrators of the 1996 Rwandan genocide to, now, as an attorney, helping many of the largest and most dynamic technology and financial entities in the world improve IP and data rights outcomes in the M&A, licensing, strategic litigation, and network theft contexts. To help clients solve IP governance, transactional, and risk management problems, Josh cofounded the first law and computer science lab in the country (CodeX), at Stanford University, as well as the top “big data” company for IP litigation (Lex Machina; founding CEO & Chief Legal Architect). However, data wins neither cases nor negotiations. We focus on client collaborations employing engineering efficiencies, design thinking, and empirical data to enhance and advance traditional legal practice. Josh’s IP work has been featured in The Wall Street Journal, The New York Times, The Economist, The Financial Times (listed, 2014 Top Ten Legal Innovator for North America), and numerous other publications. He co-taught “IP Analytics, Strategy, and Decision-Making” at Berkeley Law School, and an advanced IP media transactions seminar at Stanford Law School (“SIPX”). He received his J.D. from the University of Chicago Law School, and an A.B. in Conflict Studies (Special Concentrations) from Harvard College, m.c.l.

 

Bob Gleichauf Chief Scientist and Director of Lab41 In-Q-Tel
Joshua H. Walker Co-founder CodeX: The Stanford Center for Legal Informatics
Seminars
-

Abstract:

This research explores the conditions under which government actors and citizens recognize and incorporate the interests of others in their policy decisions and actions. To do so requires a change in beliefs about whose interests are intertwined and what it is possible and appropriate to do as a polity. This in turn demands changes in governance arrangements and, ultimately, norms of behavior.

 

Speaker Bio:

Image
margaret levi
Director of Center for Advanced Study in Behavioral Sciences (CASBS) and Professor of Political Science, Stanford. President, American Political Science Association, 2004-5. Member, National Academy of Sciences. Many publications include: Of Rule and Revenue (1988), and In the Interest of Others, with John Ahlquist (2013).

 

 

 

 

 

Margaret Levi Professor of Political Science, Stanford University Professor of Political Science, Stanford University
Seminars
Subscribe to Seminars